Tsai Yih-Chiao, Chou Yu-Ching, Wu An-Bang, Hu Chien-Ming, Chen Chau-Yang, Chen Fu-An, Lee Jen-Ai
Department of Pharmaceutical Analysis, School of Pharmacy, Taipei Medical University, No. 250, Wu-Hsing St., Taipei 11031, Taiwan, ROC.
Life Sci. 2006 Feb 16;78(12):1385-91. doi: 10.1016/j.lfs.2005.07.013. Epub 2005 Oct 12.
In researches of ketone bodies, D-3-hydroxybutyrate (D-3HB) is usually the major one which has been investigated; in contrast, little attention has been paid to L-3-hydroxybutyrate (L-3HB), because of its presence in trace amounts, its dubious metabolism, and a lack of knowledge about its sources. In the present study we determined the distributions of enantiomers of 3-hydroxybutyrate (3HB) in rat brain, liver, heart, and kidney homogenates, and we found the heart homogenate contained an enriched amount of L-3HB (37.67 microM/mg protein) which generated a significant ratio of 66/34 (D/L). The ratio was altered to be 87/13 in the diabetic rat heart homogenate. We subsequently found this changed ratio of D/L-3HB may contribute to reduce glucose utilization in cardiomyocytes. Glucose utilization by cardiomyocytes with 5 mM of D-3HB was decreased to 61% of the control, but no interference was observed when D-3HB was replaced with L-3HB, suggesting L-3HB is not utilized for the energy fuel as other ketone bodies are. In addition, the reduced glucose utilization caused by D-3HB gradually recovered in a dose-dependent manner with administration of additional L-3HB. The results gave the necessity of taking L-3HB together with D-3HB into account with regard to glucose utilization, and L-3HB may be a helpful substrate for improving inhibited cardiac pyruvate oxidation caused by hyperketonemia.
在酮体的研究中,D-3-羟基丁酸(D-3HB)通常是主要的研究对象;相比之下,L-3-羟基丁酸(L-3HB)却很少受到关注,这是因为其含量微量、代谢情况不明且对其来源缺乏了解。在本研究中,我们测定了大鼠脑、肝、心和肾匀浆中3-羟基丁酸(3HB)对映体的分布,发现心脏匀浆中L-3HB含量丰富(37.67微摩尔/毫克蛋白),其D/L比例显著为66/34。在糖尿病大鼠心脏匀浆中,该比例变为87/13。随后我们发现,这种D/L-3HB比例的变化可能有助于降低心肌细胞中的葡萄糖利用。用5毫摩尔D-3HB处理的心肌细胞的葡萄糖利用降至对照组的61%,但用L-3HB替代D-3HB时未观察到干扰,这表明L-3HB不像其他酮体那样被用作能量燃料。此外,随着额外L-3HB的给药,由D-3HB引起的葡萄糖利用减少以剂量依赖的方式逐渐恢复。这些结果表明,在考虑葡萄糖利用时,有必要将L-3HB与D-3HB一并考虑,并且L-3HB可能是改善高酮血症引起的心肌丙酮酸氧化抑制的有益底物。